BridgeMD
New treatment option for Above Knee Amputation
Official title Gait Training and Artificial Intelligence
ClinicalTrials.gov ID: NCT07265154
What this study is testing
- What it's testing
- Effect of Using Artificial Intelligence on Gait Training in Above Knee Amputation Patients
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 50
You may be able to join if
- All patients have above-knee amputations.
- All patients have no other neurological diseases affecting gait.
- All patients have no other neurological diseases affecting muscle balance.
- All patients have no other complications affecting joint ROM.
You likely can't join if
- Patients have any complications affecting joint ROM.
- Patients have any neurological condition affecting muscle balance.
- Patients have any neurological condition affecting gait.
The study team makes the final eligibility decision.
Where it's taking place
- Banhā, Benha, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banhā, Benha, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.